Denali Advisors LLC Acquires 61,700 Shares of Select Medical Holdings Co. (NYSE:SEM)

Denali Advisors LLC raised its holdings in shares of Select Medical Holdings Co. (NYSE:SEMFree Report) by 96.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 125,483 shares of the health services provider’s stock after acquiring an additional 61,700 shares during the quarter. Denali Advisors LLC owned approximately 0.10% of Select Medical worth $3,783,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. GAMMA Investing LLC bought a new stake in shares of Select Medical in the fourth quarter worth about $33,000. Allspring Global Investments Holdings LLC increased its holdings in shares of Select Medical by 6.6% in the first quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider’s stock worth $198,000 after purchasing an additional 405 shares during the last quarter. Watershed Asset Management L.L.C. increased its holdings in shares of Select Medical by 8.2% in the fourth quarter. Watershed Asset Management L.L.C. now owns 10,760 shares of the health services provider’s stock worth $253,000 after purchasing an additional 814 shares during the last quarter. Blueshift Asset Management LLC bought a new stake in shares of Select Medical in the fourth quarter worth about $288,000. Finally, Linden Thomas Advisory Services LLC increased its holdings in shares of Select Medical by 16.4% in the fourth quarter. Linden Thomas Advisory Services LLC now owns 12,429 shares of the health services provider’s stock worth $292,000 after purchasing an additional 1,750 shares during the last quarter. 89.48% of the stock is owned by institutional investors.

Insider Buying and Selling at Select Medical

In other Select Medical news, Chairman Robert A. Ortenzio sold 50,000 shares of the company’s stock in a transaction on Monday, April 8th. The shares were sold at an average price of $29.90, for a total value of $1,495,000.00. Following the sale, the chairman now directly owns 6,689,668 shares of the company’s stock, valued at $200,021,073.20. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 17.50% of the stock is owned by corporate insiders.

Select Medical Trading Up 0.4 %

Shares of Select Medical stock traded up $0.14 on Wednesday, hitting $36.30. 401,538 shares of the company traded hands, compared to its average volume of 594,507. The stock’s 50 day moving average price is $33.02 and its 200-day moving average price is $29.14. The company has a market cap of $4.72 billion, a PE ratio of 17.29, a PEG ratio of 1.67 and a beta of 1.43. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 2.30. Select Medical Holdings Co. has a 52 week low of $21.28 and a 52 week high of $36.44.

Select Medical (NYSE:SEMGet Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The health services provider reported $0.77 earnings per share for the quarter, beating analysts’ consensus estimates of $0.55 by $0.22. The firm had revenue of $1.79 billion for the quarter, compared to analyst estimates of $1.70 billion. Select Medical had a net margin of 3.97% and a return on equity of 18.11%. Equities research analysts predict that Select Medical Holdings Co. will post 2.1 EPS for the current year.

Select Medical Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 30th. Shareholders of record on Thursday, May 16th were issued a $0.125 dividend. This represents a $0.50 annualized dividend and a yield of 1.38%. The ex-dividend date was Wednesday, May 15th. Select Medical’s payout ratio is 23.81%.

Analyst Ratings Changes

Several brokerages have recently issued reports on SEM. Benchmark reaffirmed a “buy” rating and issued a $39.00 target price on shares of Select Medical in a report on Friday, May 3rd. Royal Bank of Canada lifted their price target on Select Medical from $36.00 to $40.00 and gave the stock an “outperform” rating in a research report on Monday, May 6th. Finally, StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, March 22nd. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $34.25.

Read Our Latest Report on SEM

Select Medical Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Articles

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.